comprehensive -WSS

comprehensive

author：explore 2025-09-27 13:03:26 - browse：64

light shines behind Pfizer CEO Albert Bourla as he attends a ceremony in Greece — Pfizer CEO Albert Bourla was one of a few pharmaceutical executives who donated to a failed Senate campaign in New Jersey. Giannis Papanikos/AP

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.

Administration infighting over the national stockpile

The health department’s preparedness office overseeing national stockpiles of emergency medical gear is trying to cement its Covid-era power — and meeting with congressional skepticism.

The Administration for Strategic Preparedness and Response has seen demands for protective gear and therapies rapidly expand between the Covid-19 pandemic, the 2022 mpox outbreak, and now the spread of avian flu among cows. But its management of the nation’s medical stockpile — and its efforts to replenish depleting stock — are under fresh scrutiny from lawmakers. In particular, Republicans want answers on the $850 million that Congress clawed back from ASPR’s budget, and on why that cash wasn’t spent if the stockpile needed it so badly, my co-author Sarah Owermohle reports.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Pfizer is about to make a big push in cancer. Will investors listen?

hotspot

focus

WSS

FDA's Pazdur wants cancer trials to range beyond China alone

Ohio train derailment: Experts on toxic chemical risks

Doctor of U.S. President Joe Biden says he is fit for duty

NIH documents show early flaws of $1.6 billion long Covid program

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

BMI, flaws aside, is found to be useful estimate of body fat in youth

knowledge

comprehensive

Administration infighting over the national stockpile

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

Medicare details structure of new drug price negotiation program

Are embryos people? Reproductive medicine's future depends on the answer

Guidelines to prevent youth baseball injuries need more muscle

Kaiser's Risant Health gobbled up Geisinger. Who is next?

Duchenne breakthrough therapy leaves behind pioneering families

Cord blood banking comes at a high cost to babies

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

How to save PrEP access — and even expand it

Ohio train derailment: Experts on toxic chemical risks

knowledge

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

Ohio train derailment: Experts on toxic chemical risks

Intellia reports positive results for its CRISPR

FDA's Pazdur wants cancer trials to range beyond China alone

STAT Madness 2024: Meet the contenders

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

explore

hotspot

focus

entertainment